Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793334 · ClinicalTrials.gov registry record
Underlying Mechanisms of Obesity-induced Obstructive Sleep Apnea
A clinical trial of Obesity and Obstructive Sleep Apnea, sponsored by Brandon Nokes.
- Completed
- Registry status
- 106
- Enrollment target
- 1
- Study location
NCT04793334: Completed study of Obesity and Obstructive Sleep Apnea, sponsored by Brandon Nokes.
NCT04793334 is a study of Obesity and Obstructive Sleep Apnea that has completed, run by Brandon Nokes. The registered enrollment target is 106 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04793334, a study of Obesity and Obstructive Sleep Apnea, has completed, sponsored by Brandon Nokes.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
Obesity is a common risk factor for the development of obstructive sleep apnea. However, not all subjects with obesity develop obstructive sleep apnea. This study will attempt to determine the mechanistic drivers between obesity and obstructive sleep apnea.
Primary Outcome
1\. To measure upper airway collapsibility as well as the other traits (e.g. muscle responsiveness) in both groups. The traits can be measured during sleep using our well-validated research method that mimics transient upper airway obstruction and importantly, assesses the individual's response to hypoventilation
Conditions Studied
Interventions
- PROCEDURE sleeve gastectomy
Study Locations (1)
California
- UCSD - Altman Clinical Research Institute (ACTRI) - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2021-03-20 |
| Est. Completion | 2025-05-31 |
What the finished NCT04793334 record still lists
NCT04793334 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which sleeve gastectomy is the first listed.
NCT04793334 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04793334 about?
NCT04793334 is a clinical study titled "Underlying Mechanisms of Obesity-induced Obstructive Sleep Apnea". Obesity is a common risk factor for the development of obstructive sleep apnea. However, not all subjects with obesity develop obstructive sleep apnea. This study will attempt to determine the mechanistic drivers between obesity and obstructive sleep apnea.
What is the current status of trial NCT04793334?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2021-03-20. Estimated completion is 2025-05-31.
What conditions does trial NCT04793334 study?
This clinical trial studies the following conditions: Obesity, Obstructive Sleep Apnea.
What interventions are being tested in trial NCT04793334?
The interventions under investigation include: sleeve gastectomy (PROCEDURE).
Who is sponsoring clinical trial NCT04793334?
This trial is sponsored by Brandon Nokes, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04793334 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04793334's enrollment target sits among peer trials
106 464th of 1053 higher than 590 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI